1. Peter MacCallum Cancer Centre, Melbourne, VIC, Australia;
2. Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL;
3. Department of Dermatology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA;
4. Department of Medical Oncology, Royal North Shore Hospital, St Leonards, NSW, Australia;
5. Department of Dermatology, Stanford University School of Medicine, Redwood City, CA;
6. University of Colorado Denver, School of Medicine, Aurora, CO;
7. Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia;
8. Division of Medical Oncology, Department of Medicine, Washington University School of Medicine, St. Louis, MO;
9. Royal Brisbane & Women's Hospital and University of Queensland, Brisbane, QLD, Australia;
10. University Hospital Essen, Essen and German Cancer Consortium, Essen, Germany;
11. Schleswig-Holstein University Hospital, Kiel, Germany;
12. Regeneron Pharmaceuticals, Inc., Basking Ridge, NJ;
13. Regeneron Pharmaceuticals, Inc., Tarrytown, NY;
14. Regeneron Pharmaceuticals, Inc., London, NY, United Kingdom;
15. Departments of Dermatology and Head and Neck Surgery, University of Texas, MD Anderson Cancer Center, Houston, TX;